Outcomes of passive-active immunoprophylaxis given to infants of mothers infected with hepatitis B virus in Babol, Iran

Journal of Clinical Virology

Volumn 49, Issue 4, 2010, Pages 283-285

  Soleimani Amiri, Mohammad Jafar ^a   Hasanjani Roushan, Mohammad Reza ^a   Baiany, Masomeh ^a   Taheri, Hassan ^a   Hasanjani Roushan, Mahbobeh ^a  

^a BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hepatitis B immunoglobulin; Hepatitis B vaccine; Hepatitis B virus; Infant

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ACTIVE IMMUNIZATION; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOPROPHYLAXIS; INFANT; IRAN; OUTCOME ASSESSMENT; PASSIVE IMMUNIZATION; PRIORITY JOURNAL;

CHEMOPREVENTION; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOTHERAPY, ACTIVE; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; IRAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TREATMENT OUTCOME;

EID: 78149495707     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2010.08.009     Document Type: Article

References (22)

1. Mahoney F.J. Update on diagnosis. Management, and prevention of hepatitis B virus infection. Clin Microbiol Rev 1999, 12:351-366.
2. Ranger-Rogez S., Denis F. Hepatitis B mother to child transmission. Expert Rev Anti-Infect Ther 2004, 2:133-145.
3. Koziel M.J., Siddiqui A. Hepatitis B virus and hepatitis D virus. Principles and practice of infectious diseases 2005, 1864-1890. Churchill Livingstone, Philadelphia. 6th ed. G.L. Mandell, J.E. Bennett, E. Dolin (Eds.).
4. Shapiro C.N. Epidemiology of hepatitis B. Pediatr Infect Dis J 1993, 12:433-437.
5. CDC Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. MMWR 1991, 40(RR-13):1-8.
6. Snyder J.D., Pickering L.K. Viral hepatitis. Nelson textbook of pediatrics 2000, 768-773. WB Saunders, Philadelphia. R.M. Kliengman, H.B. Jenson (Eds.).
7. Lee C., Gong Y., Brok J., Boxall E.H., Gluud C. Effect of hepatitis B immunization in newborn infants of mothers positive for hepatitis B surface antigen: systemic review and meta-analysis. BMJ 2006, 332:328-336.
8. Xiao X.M., Li A.Z., Chen X., Zhu Y.K., Miao J. Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy. Int J Gynecol Obstet 2007, 96:167-170.
9. Tremolada S., Delbue S., Ferrante P. Viral infections of the fetus and newborn infant. Pediatr Med Chir 2008, 30:177-191.
10. Vranckx R., Alisiahbana A., Meheus A. Hepatitis B virus vaccination and antenatal transmission of HBV markers to neonates. J Viral Hepat 1999, 6:135-139.
11. Zhu Q.R., Yu G.J., Yu H., Gu X.H., Lu Q., Gu X.H., et al. A randomized control trial on interruption of HBV transmission in uterus. Chin Med J 2003, 116:685-687.
12. Wiseman E., Fraser M.A., Holden S., Glass A., Kidson B.L., Heron L.G., et al. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust 2009, 190:489-492.
13. Hill J.B., Sheffield J.S., Kim M.J., Alexander J.M., Sercely B., Wendel G.D. Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers. Obstet Gynecol 2002, 99:1049-1052.
14. Guo Y., Liu J., Meng L., Meina H., Du Y. Survey of HBsAg-positive pregnant women and their infants regarding measures to prevent maternal-infantile transmission. BMC Infect Dis 2010, 15:26.
15. Sloan D., Ramsay M., Prasad L., Gelb D., Teo C.G. Prevention of perinatal transmission of hepatitis B to babies at high risk: an evaluation. Vaccine 2005, 23:5500-5508.
16. Wang Z., Zhang J., Yang H., Li X., Wen S., Guo Y., et al. Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies. J Med Virol 2003, 71:360-366.
17. Zonneveld M.V., van Nunen A.B., Niesters H.G.M., Man R.A., Schalm S.W., Janssen H.L.A. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus. J Viral Hepat 2003, 10:294-297.
18. van Nunen A.B., de Man R.A., Heistink R.A., et al. Lamivudine in the last 4 weeks of pregnancy to prevent perinatal transmission in highly viremic chronic hepatitis B patients. J Hepatol 2000, 32:1040-1042.
19. Euler G.L., Copeland J.R., Rangel M.C., Williams W.W. Antibody response to postexposure prophylaxis in infants born to hepatitis B surface antigen-positive women. Pediatr Infect Dis J 2003, 22:123-129.
20. Prakash C., Bhatia R., Kumari S., et al. Response to hepatitis B vaccination in high-risk population. J Commun Dis 2000, 32:17-21.
21. Hasanjani Roushan M.R., Zahed Pasha Y., Saghebi R., Kohi F. Revaccination of non-responding infants delivered by HBsA positive mothers. Eur J Clin Microbiol Infect Dis 2005, 24:434-435.
22. Roome A., Rak M., Hadler J. Follow-up of infants of hepatitis B-infected women after hepatitis B vaccination, Connecticut, 1994 to 1997. Pediatr Infect Dis J 2000, 19:573-575.